ATRA
Atara Biotherapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$8.29-1.19%
Price as of Jul 20, 2026
ATRA valuation
Atara Biotherapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 31.10x
- P/E 2026E
- 39.34x
- P/E 2027E
- 52.60x
- P/E 2028E
- 13.00x
- P/S forward
- 4.02x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.00x
- Price / sales
- 3.23x
- Price / cash flow
- -2.89x
Enterprise value
- Enterprise value
- $76.4M
- EV / sales
- 3.30x
- EV / EBITDA
- -13.94x
- EV / EBIT
- -12.11x
- Market cap
- $74.7M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.